Stock listing
BOATS:TRDA Entrada Therapeutics, Inc. Stock
US listing (BOATS) of Entrada Therapeutics, Inc. · home listing NASDAQ:TRDA
Follow Entrada Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:TRDA
$5.11 USD +0.58 (+12.7%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:TRDA
- Day range
- $4.44 – $5.13 USDNov 2, 2026
- Volume
- 651,953 sharesNov 2, 2026
- Market cap
- $199.0M USDAt the close on Nov 2, 2026 · price × 38.94M shares outstanding
- 52-week range
- $4.11 – $16.45 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $2.14M USDMedian day 319,100 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:TRDA · Home | $5.11 USD | +0.575 (+12.7%) | 651,953 | $4.58 | $5.13 | $4.44 | $4.535 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:TRDA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $5.11 | +0.575 | +12.7% | $4.58 | $5.13 | $4.44 | 651,953 | |
| $4.535 | +0.135 | +3.1% | $4.37 | $4.545 | $4.26 | 317,344 | |
| $4.40 | -0.44 | -9.1% | $4.76 | $5.07 | $4.35 | 479,051 | |
| $4.84 | +0.43 | +9.8% | $4.38 | $4.88 | $4.33 | 409,094 | |
| $4.41 | -0.34 | -7.2% | $4.72 | $4.85 | $4.36 | 413,453 | |
| $4.75 | +0.34 | +7.7% | $4.46 | $4.945 | $4.46 | 617,085 | |
| $4.41 | -0.32 | -6.8% | $4.67 | $4.695 | $4.385 | 191,500 | |
| $4.73 | +0.08 | +1.7% | $4.71 | $4.78 | $4.555 | 462,100 | |
| $4.65 | -0.34 | -6.8% | $5.02 | $5.035 | $4.60 | 323,800 | |
| $4.99 | +0.17 | +3.5% | $4.81 | $5.27 | $4.79 | 403,100 | |
| $4.82 | +0.45 | +10.3% | $4.36 | $4.84 | $4.27 | 585,600 | |
| $4.37 | -0.41 | -8.6% | $4.79 | $4.85 | $4.345 | 371,800 | |
| $4.78 | +0.23 | +5.1% | $4.52 | $4.96 | $4.425 | 514,800 | |
| $4.55 | -0.31 | -6.4% | $4.69 | $4.77 | $4.109 | 740,100 | |
| $4.86 | -0.64 | -11.6% | $5.50 | $5.56 | $4.83 | 255,200 | |
| $5.50 | -0.17 | -3.0% | $5.64 | $5.69 | $5.48 | 198,600 | |
| $5.67 | +0.14 | +2.5% | $5.52 | $5.75 | $5.44 | 209,400 | |
| $5.53 | -0.08 | -1.4% | $5.52 | $5.59 | $5.25 | 361,500 | |
| $5.61 | +0.19 | +3.5% | $5.33 | $5.66 | $5.30 | 297,400 | |
| $5.42 | -0.06 | -1.1% | $5.52 | $5.52 | $5.25 | 315,900 | |
| $5.48 | +0.10 | +1.9% | $5.38 | $5.48 | $5.15 | 463,800 | |
| $5.38 | -0.30 | -5.3% | $5.77 | $6.22 | $5.17 | 463,700 | |
| $5.68 | -0.67 | -10.6% | $6.32 | $6.36 | $5.60 | 425,100 | |
| $6.35 | +0.09 | +1.4% | $6.20 | $6.39 | $6.125 | 239,900 | |
| $6.26 | +0.04 | +0.6% | $6.25 | $6.43 | $6.08 | 268,600 | |
| $6.22 | +0.06 | +1.0% | $6.13 | $6.24 | $5.925 | 442,600 | |
| $6.16 | -0.06 | -1.0% | $6.23 | $6.245 | $6.01 | 374,000 | |
| $6.22 | -0.28 | -4.3% | $6.47 | $6.47 | $6.14 | 319,100 | |
| $6.50 | -0.21 | -3.1% | $6.71 | $6.71 | $6.37 | 282,800 | |
| $6.71 | +0.07 | +1.1% | $6.71 | $6.93 | $6.654 | 195,500 | |
| $6.64 | -0.11 | -1.6% | $6.81 | $6.81 | $6.455 | 375,300 | |
| $6.75 | -0.15 | -2.2% | $6.85 | $6.89 | $6.60 | 354,400 | |
| $6.90 | +0.01 | +0.1% | $6.91 | $7.05 | $6.665 | 297,400 | |
| $6.89 | +0.01 | +0.1% | $6.92 | $6.99 | $6.74 | 249,200 | |
| $6.88 | -0.17 | -2.4% | $7.05 | $7.05 | $6.67 | 247,800 | |
| $7.05 | +0.25 | +3.7% | $6.80 | $7.07 | $6.72 | 336,100 | |
| $6.80 | +0.38 | +5.9% | $6.49 | $6.81 | $6.29 | 291,800 | |
| $6.42 | -0.69 | -9.7% | $7.00 | $7.175 | $6.38 | 448,100 | |
| $7.11 | -0.41 | -5.5% | $7.47 | $7.55 | $7.02 | 382,000 | |
| $7.52 | +0.39 | +5.5% | $7.02 | $7.70 | $6.945 | 514,200 | |
| $7.13 | -0.04 | -0.6% | $7.11 | $7.17 | $7.00 | 341,700 | |
| $7.17 | -0.13 | -1.8% | $7.31 | $7.423 | $7.04 | 395,600 | |
| $7.30 | +0.23 | +3.3% | $7.07 | $7.34 | $6.96 | 306,500 | |
| $7.07 | +0.02 | +0.3% | $6.95 | $7.179 | $6.80 | 205,500 | |
| $7.05 | +0.05 | +0.7% | $6.84 | $7.17 | $6.76 | 450,400 | |
| $7.00 | -0.27 | -3.7% | $7.18 | $7.24 | $6.935 | 111,600 | |
| $7.27 | +0.27 | +3.9% | $7.02 | $7.37 | $6.80 | 248,600 | |
| $7.00 | -0.62 | -8.1% | $7.55 | $7.64 | $6.954 | 229,300 | |
| $7.62 | +0.29 | +4.0% | $7.39 | $7.67 | $7.39 | 269,980 | |
| $7.33 | -0.24 | -3.2% | $7.58 | $7.58 | $7.12 | 184,249 | |
| $7.57 | -0.03 | -0.4% | $7.64 | $7.735 | $7.44 | 141,000 | |
| $7.60 | -0.18 | -2.3% | $7.76 | $7.765 | $7.30 | 250,000 | |
| $7.78 | +0.51 | +7.0% | $7.49 | $7.79 | $7.395 | 241,800 | |
| $7.27 | -0.05 | -0.7% | $7.21 | $7.43 | $7.16 | 129,800 | |
| $7.32 | -0.14 | -1.9% | $7.33 | $7.56 | $7.25 | 193,100 | |
| $7.46 | +0.01 | +0.1% | $7.45 | $7.53 | $7.21 | 238,000 | |
| $7.45 | -0.22 | -2.9% | $7.74 | $7.765 | $7.369 | 236,400 | |
| $7.67 | +0.63 | +8.9% | $7.03 | $7.68 | $6.93 | 263,600 | |
| $7.04 | +0.09 | +1.3% | $7.00 | $7.27 | $6.93 | 264,100 | |
| $6.95 | +0.08 | +1.2% | $6.87 | $7.26 | $6.83 | 411,800 | |
| $6.87 | 0.00 | 0.0% | $6.94 | $7.085 | $6.75 | 458,000 | |
| $6.87 | -0.19 | -2.7% | $7.05 | $7.11 | $6.74 | 270,000 | |
| $7.06 | -0.18 | -2.5% | $7.47 | $7.47 | $6.85 | 591,500 | |
| $7.24 | -0.02 | -0.3% | $6.945 | $7.97 | $6.945 | 663,100 | |
| $7.26 | +0.47 | +6.9% | $6.83 | $7.31 | $6.64 | 500,500 |
- Ticker
- BOATS:TRDA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 21, 2026
Entrada Therapeutics Appoints Linea Aspesi as Chief People Officer
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 50 slides
Latest news
Entrada Therapeutics Appoints Linea Aspesi as Chief People Officer
Oct 21, 2026
Closed $4.65 (-6.8%) on Oct 21, 2026
Entrada Therapeutics Announces Positive Results from the First Cohort of Participants with Duchenne Muscular Dystrophy (DMD) in the Phase 1/2 ELEVATE-45-201 Study of ENTR-601-45
Oct 14, 2026
Closed $4.55 (-6.4%) on Oct 14, 2026
Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Top Dose of 18 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study
Oct 14, 2026
Closed $4.55 (-6.4%) on Oct 14, 2026
Entrada Therapeutics Announces Recipients of Fourth Annual DREAMS Grant Program
Sep 10, 2026
Closed $6.42 (-9.7%) on Sep 10, 2026
Entrada Therapeutics Reports Second Quarter 2026 Financial Results
Aug 5, 2026
Closed $7.06 (-2.5%) on Aug 5, 2026
Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 10 mg/kg in Entrada Therapeutics’ ELEVATE-45-201 Study
Jun 2, 2026
Closed $6.64 (-3.9%) on Jun 2, 2026
Entrada Therapeutics Announces Positive Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study
May 7, 2026
Closed $6.85 (-57.3%) on May 7, 2026
Entrada Therapeutics to Announce Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study on May 7, 2026
May 6, 2026
Closed $6.85 (-57.3%) on May 7, 2026
Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Feb 26, 2026
Closed $12.79 (+6.8%) on Feb 26, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 50 slides · August 2026
Investor Presentation (May 2026)
Investor deck · 51 slides · May 19, 2026
2025 J.P. Morgan Healthcare Conference
Conference · 25 slides · Jan 15, 2025
MDF 2022
Conference · 12 slides · 2022
Entrada Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 15 in the last 12 months · 73 in all · newest Oct 21, 2026 · oldest 2021
- Decks
- 4 decks · latest August 2026
Where Entrada Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TRDA · Home listing | NASDAQ | United States | USD |
| BOATS:TRDA · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Entrada Therapeutics, Inc.